Literature DB >> 23064486

The influence of VKORC1 3730 G > A polymorphism on warfarin dose: reply.

Michela Cini, Cristina Legnani, Benilde Cosmi, Giuliana Guazzaloca, Lelia Valdrè, Mirella Frascaro, Gualtiero Palareti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23064486     DOI： 10.1007/s00228-012-1431-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms.

Authors:  Michela Cini; Cristina Legnani; Benilde Cosmi; Giuliana Guazzaloca; Lelia Valdrè; Mirella Frascaro; Gualtiero Palareti
Journal:  Eur J Clin Pharmacol       Date:  2012-02-19       Impact factor: 2.953

2.  Common VKORC1 and GGCX polymorphisms associated with warfarin dose.

Authors:  M Wadelius; L Y Chen; K Downes; J Ghori; S Hunt; N Eriksson; O Wallerman; H Melhus; C Wadelius; D Bentley; P Deloukas
Journal:  Pharmacogenomics J       Date:  2005       Impact factor: 3.550

3.  Optimization of warfarin dose by population-specific pharmacogenomic algorithm.

Authors:  A Pavani; S M Naushad; Y Rupasree; T R Kumar; A R Malempati; R K Pinjala; R C Mishra; V K Kutala
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

4.  Genetic, clinical and behavioural determinants of vitamin K-antagonist dose--explored through multivariable modelling and visualization.

Authors:  Jane Skov; Else-Marie Bladbjerg; Morten A Rasmussen; Johannes J Sidelmann; Anja Leppin; Jørgen Jespersen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-10-07       Impact factor: 4.080

Review 5.  Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.

Authors:  Andrea L Jorgensen; Richard J FitzGerald; James Oyee; Munir Pirmohamed; Paula R Williamson
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.